Cite
MLA Citation
Akinsola Oyelakin et al.. “EHF is a novel regulator of cellular redox metabolism and predicts patient prognosis in HNSCC.” NAR cancer, no. 2, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100156405252.0x000001
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Akinsola Oyelakin et al.. “EHF is a novel regulator of cellular redox metabolism and predicts patient prognosis in HNSCC.” NAR cancer, no. 2, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100156405252.0x000001